Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Funding for CTSA Program hubs to advance clinical translation, partnerships, research, and training for faster, more inclusive medical advancements.
Funder: National Institutes of Health
Due Dates: May 28, 2025 | September 29, 2025 | January 28, 2026 | May 28, 2026 | September 28, 2026 | January 28, 2027 | May 28, 2027 | September 28, 2027
Funding Amounts: Direct costs per year: $2.6M–$6.5M (tiered by institutional NIH funding); up to 7 years per award; pilot projects: $25K–$50K each; CTS Research Program: up to $500K/year.
Summary: Supports CTSA Program hubs to accelerate clinical and translational science, foster innovation, partnerships, and workforce development, and rapidly address public health needs.
Key Information: Requires concurrent K12 application; clinical trial support limited to phase IIB (except rare disease phase III); non-domestic organizations not eligible to apply.
Description
This opportunity funds Clinical and Translational Science Award (CTSA) Program hubs, which serve as central nodes in a national consortium dedicated to advancing clinical and translational science (CTS). The program aims to accelerate the development and dissemination of new treatments, improve research efficiency and effectiveness, foster innovative partnerships, address health disparities, and provide rapid response capabilities for urgent public health needs. Hubs are expected to demonstrate leadership in scientific and operational innovation, collaboration, workforce development, and community engagement.
